Impact BioMedical Inc. (IBO) Insider Trading Activity

AMEX$4.16+0.14 (3.48%)
Market Cap
$34.35M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
577 of 849
Rank in Industry
334 of 491

IBO Insider Trading Activity

IBO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$59,522
6
100

Related Transactions

DSS, INC.10 percent owner
0
$0
3
$1,686
$-1,686
Macko Todd DChief Financial Officer
0
$0
2
$25,330
$-25,330
Grady Jasondirector
0
$0
1
$32,505
$-32,505

About Impact BioMedical Inc.

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to …

Insider Activity of Impact BioMedical Inc.

Over the last 12 months, insiders at Impact BioMedical Inc. have bought $0 and sold $59,522 worth of Impact BioMedical Inc. stock.

On average, over the past 5 years, insiders at Impact BioMedical Inc. have bought $80,516 and sold $2.87M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 200 shares for transaction amount of $310 was made by DSS, INC. (10 percent owner) on 2025‑03‑20.

List of Insider Buy and Sell Transactions, Impact BioMedical Inc.

2026-09-24SaleDSS, INC.10 percent owner
156
0.0023%
$7.06
$1,101
-28.94%
2026-09-23SaleDSS, INC.10 percent owner
27
0.0003%
$6.95
$188
-39.37%
2026-09-22SaleDSS, INC.10 percent owner
723
0.0006%
$0.55
$398
-39.64%
2026-03-27SaleMacko Todd DChief Financial Officer
43,400
0.3487%
$0.56
$24,369
-16.41%
2026-03-25SaleMacko Todd DChief Financial Officer
1,600
0.0132%
$0.60
$961
-17.55%
2026-03-23SaleGrady Jasondirector
50,000
0.402%
$0.65
$32,505
-25.43%
2025-05-27SaleDSS, INC.10 percent owner
45,400
0.3798%
$0.54
$24,530
+7.42%
2025-05-22SaleDSS, INC.10 percent owner
115,600
0.955%
$0.55
$63,476
+4.32%
2025-04-04SaleDSS, INC.10 percent owner
890,800
7.7532%
$0.95
$845,013
-42.96%
2025-04-03SaleChan Heng Fai Ambrosedirector
351,555
3.2601%
$0.49
$174,020
+18.26%
2025-04-01SaleChan Heng Fai Ambrose
2.23M
15.8023%
$1.17
$2.6M
-33.04%
2025-03-31SaleChan Heng Fai Ambrose
300,000
3.0814%
$1.03
$308,400
-36.89%
2025-03-27SaleDSS, INC.10 percent owner
47,681
0.4547%
$2.50
$119,255
-75.91%
2025-03-26SaleDSS, INC.10 percent owner
58,139
0.7196%
$3.13
$182,134
-75.04%
2025-03-21SaleDSS, INC.10 percent owner
333,200
1.9273%
$3.30
$1.1M
-88.93%
2025-03-20SaleDSS, INC.10 percent owner
53,280
1.0421%
$4.68
$249,350
-73.60%
2025-03-20PurchaseDSS, INC.10 percent owner
200
0.0013%
$1.55
$310
-73.60%
2024-12-05PurchaseHeuszel Frank DChief Executive Officer
500
0.0043%
$2.26
$1,129
-72.91%
2024-12-02SaleDSS, INC.10 percent owner
20
0.0002%
$2.90
$58
-75.24%
2024-11-27PurchaseHeuszel Frank DChief Executive Officer
500
0.0041%
$2.61
$1,305
-76.89%
Total: 27
*Gray background shows transactions not older than one year

IBO Institutional Investors: Active Positions

Increased Positions10+45.45%933,246+173.4%
Decreased Positions7-31.82%31,602-5.87%
New Positions4New175,667New
Sold Out Positions<1Sold Out36Sold Out
Total Postitions25+13.64%1M+167.52%

IBO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$131.000.24%252,73000%2025-09-30
Vanguard Group Inc$53.000.1%102,905+70,468+217.25%2025-09-30
Geode Capital Management, Llc$23.000.04%45,109-4,760-9.54%2025-09-30
Two Sigma Investments, Lp$16.000.03%31,500+8,800+38.77%2025-09-30
Two Sigma Securities, Llc$15.000.03%28,441+28,441New2025-09-30
Susquehanna International Group, Llp$11.000.02%20,962-9,862-32%2025-09-30
Ubs Group Ag$10.000.02%20,088-19,637-49.43%2025-09-30
State Street Corp$6.000.01%11,79700%2025-09-30
Mason & Associates Inc$5.000.01%10,000+10,000New2025-09-30
Morgan Stanley$5.000.01%9,266+9,266New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.